Pharmacokinetic profiles of sertraline in pregnancy as a predictor of postpartum depressive symptoms
Sertraline pharmacokinetic profiles varied across pregnant women and were associated with postpartum depressive symptoms. The use of therapeutic monitoring may provide clinical insight that can be useful for identifying patients with a potential toward depressive symptoms.
Authors
- Michael D. Evans (ORCID: https://orcid.org/0000-0001-7449-3993)
- D. Jeffrey Newport
- Maged M. Costantine (ORCID: https://orcid.org/0000-0003-4076-469X)
- Angela K. Birnbaum (ORCID: https://orcid.org/0000-0002-3969-4906)
- James Ritchie (ORCID: https://orcid.org/0000-0001-7740-348X)
- Zachary N. Stowe (ORCID: https://orcid.org/0000-0001-6320-8042)
- Catherine M.T. Sherwin (ORCID: https://orcid.org/0000-0002-0844-3207)
- Marc Kalin
- Sílvia M. Illamola (ORCID: https://orcid.org/0000-0003-3245-1626)
Institutions
- University of Minnesota (US)
- University of Wisconsin–Madison (US)
- Emory University (US)
- The University of Western Australia (AU)
- The Ohio State University Wexner Medical Center (US)
- Southern California Clinical and Translational Science Institute (US)
- Center for Asian American Media (US)
- The University of Texas at Austin (US)
Publication Details
- Journal
- British Journal of Clinical Pharmacology
- Published
- 2025-10-07
- DOI
- https://doi.org/10.1002/bcp.70283
- Primary Topic
- Maternal Mental Health During Pregnancy and Postpartum
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- National Institutes of Health
- National Institute of Mental Health
- National Institute of Child Health and Human Development
- Office of Research on Women's Health
- National Center for Advancing Translational Sciences
- Eunice Kennedy Shriver National Institute of Child Health and Human Development